CORRIGENDUM FOR “Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM”

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672806/
https://www.ncbi.nlm.nih.gov/pubmed/33241168
http://dx.doi.org/10.1210/jendso/bvaa134
_version_ 1783611208915484672
collection PubMed
description
format Online
Article
Text
id pubmed-7672806
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-76728062020-11-24 CORRIGENDUM FOR “Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM” J Endocr Soc Corrigendum Oxford University Press 2020-11-18 /pmc/articles/PMC7672806/ /pubmed/33241168 http://dx.doi.org/10.1210/jendso/bvaa134 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Corrigendum
CORRIGENDUM FOR “Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM”
title CORRIGENDUM FOR “Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM”
title_full CORRIGENDUM FOR “Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM”
title_fullStr CORRIGENDUM FOR “Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM”
title_full_unstemmed CORRIGENDUM FOR “Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM”
title_short CORRIGENDUM FOR “Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM”
title_sort corrigendum for “glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter inhibitors for treatment of t2dm”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672806/
https://www.ncbi.nlm.nih.gov/pubmed/33241168
http://dx.doi.org/10.1210/jendso/bvaa134

Ejemplares similares